Tech
Health startup AccuRx helped organize 21 million COVID-19 vaccines. Check out the 36-slide pitch deck it used to raise $38 million.
subscribers.
Become an Insider
and start reading now.
Have an account? .
- UK health startup AccuRx has raised $38 million in fresh funding.
- The company builds communication tools for primary care practitioners in the UK’s NHS.
- AccuRx’s booking services helped the UK’s health service administer 21 million COVID-19 vaccines.
A startup that enables doctors to send patients’ sick notes and referral letters via SMS has raised $38 million as demand for companies making healthcare provision more efficient took off in the pandemic.
London-based AccuRx provides a doctor-to-patient platform that also allows practitioners to chat via video, in some cases removing the need for a face-to-face appointment. Initially free and extremely popular during the pandemic, the video product has now been split into a premium “plus” offering and a “lite” version with reduced features.
subscribers.
Become an Insider
and start reading now.
Have an account? .
AccuRx’s technology is used by doctors’ surgeries within the UK’s National Health Service (NHS), which has been relatively slow to adopt online consultations.
AccuRx, founded by Entrepreneur First alumni Jacob Haddad and Laurence Bargery, has also been heavily involved in the UK’s COVID-19 vaccine rollout. The startup says its booking platform was used to organize 21 million vaccinations — around a quarter of the UK’s total.
“This funding round allows us to go after new areas of demand,” Bargery, AccuRx’s chief technology officer, told Insider. “We’re looking forward to doubling down in other care sectors like secondary care and also going deeper within GP surgeries.”
AccuRx grew from around 60 staff at the beginning of 2021 to 120 now. Bargery said the firm may hit as many as 300 by the end of 2022, with a focus on adding engineers and a VP of people.
“Inefficient communication between nurses, doctors, general practitioners, to name a few, is tremendously detrimental to patients,” said Oliver Heimes, partner at Lakestar, in a statement. “We see this issue in healthcare sectors around the world and the pandemic has only heightened the need for action.”
The Series B round was led by Lakestar with participation from British Patient Capital, Latitude, Atomico, Trusted Insight and Encore Capital. The startup last raised a $12.2 million Series A in February 2019.
Check out AccuRx’s pitch deck:
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx
accuRx